Episode Details
Back to EpisodesCOVID-19 clinical update #72 with Dr. Daniel Griffin
Episode 783
Published 4 years, 5 months ago
Description
In COVID-19 clinical update #72, Daniel Griffin covers long term symptoms in children, outcomes for MIS-C, recent guidance from the American Academy of Pediatrics, a large well traced outbreak of delta variant, low dose mRNA vaccination generates durable T cell memory and antibodies, protective immunity in recovered patients, assessment of BinaxNOW, no effect of oral azithromycin, post-discharge symptoms in Nigeria, and therapeutics for low and middle income countries.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Long COVID in children (JAMA)
- Outcomes after MIS-C (Pediatrics)
- Guidance for school opening (Amer Acad Ped)
- Infection in well traced delta outbreak (medRxiv)
- Immune memory 8 months post-infection (Science)
- Low dose mRNA vaccine enhances T cells (medRxiv)
- Protection after infection (Lancet)
- Assessment of BinaxNOW (Sci Rep)
- Rapid POC antigen tests (Cochrane Rev)
- Oral azithromycin ineffective (JAMA)
- Post discharge symptoms in Nigeria (AJTMH)
- Therapeutics for low and middle income countries (AJTMH)
- Letters read on TWiV 783
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to daniel@microbe.tv